Jon Himoff Named in CIO 100 UK 2026 for Leading Image Analysis Group
News related to:Image Analysis Group · 2 min read
LONDON, UNITED KINGDOM, October 7, 2026 /CourierPR/ -- Image Analysis Group's Chief Product Officer Jon Himoff has been named in the CIO 100 UK 2026, a prestigious list recognizing 100 of the UK's most innovative and impactful technology leaders. The award was announced at the CIO 100 Awards Ceremony and Dinner at The Royal Lancaster, London, on September 24, 2026.
Himoff, who leads product, technology, and AI strategy at Image Analysis Group (IAG), is credited with overseeing the development of DYNAMIKA™, the company's proprietary platform for imaging clinical trials. This platform is designed to assess whether new drugs are safe and effective, providing sponsors with the evidence needed for regulatory approval.
At IAG, Himoff's experience spans multiple roles, including founder, product leader, developer, and AI architect. He emphasizes the collaborative nature of the award, crediting the product leaders, engineers, QA, compliance, and support teams who designed and built DYNAMIKA™ alongside him.
DYNAMIKA™, built for imaging clinical trials, offers several unique features. It is an enterprise platform designed and built from the ground up, covering the full trial lifecycle from site qualification to database lock. Automated quality control checks ensure that every image uploaded adheres to the protocol, flagging any deviations immediately. This ensures sponsors receive real-time feedback, enhancing the efficiency of their clinical trials.
The platform also takes an enterprise approach, bringing all of a sponsor's studies, sites, and readers together on a shared infrastructure. This approach reduces startup time and streamlines the process of accessing historical data, making it easier for sponsors to make informed decisions.
Image Analysis Group (IAG) is a trusted partner to biotech and pharmaceutical companies, combining deep expertise in medical imaging with its proprietary platform, DYNAMIKA™. Founded nearly 20 years ago, IAG has supported more than 700 clinical trials worldwide, helping to reduce risk in clinical development and accelerate the delivery of life-saving therapies to patients.
The article highlighted how DYNAMIKA™ was designed and built from the ground up as an enterprise platform, supporting imaging endpoints in various therapeutic areas, including oncology, obesity, metabolic disease, rheumatology, and musculoskeletal disease.
Himoff's recognition underscores IAG's commitment to leveraging AI and technology to drive innovation in clinical trials.